Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Income from Non-Controlling Interests: 2009-2023

Historic Income from Non-Controlling Interests for Ironwood Pharmaceuticals (IRWD) over the last 3 years, with Dec 2023 value amounting to -$29.3 million.

  • Ironwood Pharmaceuticals' Income from Non-Controlling Interests was N/A to -$658,000 in Q4 2023 from the same period last year, while for Dec 2023 it was -$579,000, marking a year-over-year change of. This contributed to the annual value of -$29.3 million for FY2023, which is N/A change from last year.
  • Per Ironwood Pharmaceuticals' latest filing, its Income from Non-Controlling Interests stood at -$29.3 million for FY2023, which was down 2,715.52% from $1.1 million recorded in FY2010.
  • Ironwood Pharmaceuticals' 5-year Income from Non-Controlling Interests high stood at -$29.3 million for FY2023, and its period low was -$29.3 million during FY2023.
  • Moreover, its 1-year median value for Income from Non-Controlling Interests was -$29.3 million (2023), whereas its average is -$29.3 million.